United States (US) Antimicrobial Resistance Diagnostics Market (2025-2031) | Forecast, Analysis, Companies, Industry, Size & Revenue, Trends, Outlook, Value, Segmentation, Share, Growth, Competitive Landscape

Name: United States (US) Antimicrobial Resistance Diagnostics Market (2025-2031) | Forecast & Analysis
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Technology (Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care, Others), By Pathogen (Drug Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS), Others), By End-user (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others) And Competitive Landscape

Product Code: ETC9959327	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Sumit Sagar	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Antimicrobial Resistance Diagnostics Market Outlook
Market Size of United States (US) Antimicrobial Resistance Diagnostics Market, 2024
Forecast of United States (US) Antimicrobial Resistance Diagnostics Market, 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Revenues & Volume for the Period 2021- 2031
United States (US) Antimicrobial Resistance Diagnostics Market Trend Evolution
United States (US) Antimicrobial Resistance Diagnostics Market Drivers and Challenges
United States (US) Antimicrobial Resistance Diagnostics Price Trends
United States (US) Antimicrobial Resistance Diagnostics Porter's Five Forces
United States (US) Antimicrobial Resistance Diagnostics Industry Life Cycle
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Microbiology Culture for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Immunoassay for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By PCR for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By NGS for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Mass Spectrometry for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Rapid & Point of Care for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Pathogen for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Drug Resistant Streptococcus Pneumoniae (DRSP) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Drug Resistant Campylobacter (DRC) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Clostridium Difficile (CD) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Methicillin Resistant Staphylococcus Aureus (MRSA) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Drug Resistant Neisseria Gonorrhoeae (DRNG) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Drug Resistant Salmonella (DRNTS) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By End-user for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Diagnostic Laboratories for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Pharmaceutical & Biotechnology Companies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Antimicrobial Resistance Diagnostics Import Export Trade Statistics
Market Opportunity Assessment By Technology
Market Opportunity Assessment By Pathogen
Market Opportunity Assessment By End-user
United States (US) Antimicrobial Resistance Diagnostics Top Companies Market Share
United States (US) Antimicrobial Resistance Diagnostics Competitive Benchmarking By Technical and Operational Parameters
United States (US) Antimicrobial Resistance Diagnostics Company Profiles
United States (US) Antimicrobial Resistance Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Antimicrobial Resistance Diagnostics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Antimicrobial Resistance Diagnostics Market - Industry Life Cycle

3.4 United States (US) Antimicrobial Resistance Diagnostics Market - Porter's Five Forces

3.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F

3.7 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United States (US) Antimicrobial Resistance Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of antibiotic-resistant infections in the US

4.2.2 Growing awareness among healthcare professionals and patients about the importance of antimicrobial resistance diagnostics

4.2.3 Technological advancements leading to the development of more accurate and rapid diagnostic tools

4.3 Market Restraints

4.3.1 High costs associated with antimicrobial resistance diagnostics tests

4.3.2 Limited access to advanced diagnostic technologies in certain healthcare facilities

4.3.3 Stringent regulatory requirements for approval of new diagnostic tests

5 United States (US) Antimicrobial Resistance Diagnostics Market Trends

6 United States (US) Antimicrobial Resistance Diagnostics Market, By Types

6.1 United States (US) Antimicrobial Resistance Diagnostics Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Microbiology Culture, 2021- 2031F

6.1.4 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Immunoassay, 2021- 2031F

6.1.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F

6.1.6 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F

6.1.7 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Mass Spectrometry, 2021- 2031F

6.1.8 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Rapid & Point of Care, 2021- 2031F

6.2 United States (US) Antimicrobial Resistance Diagnostics Market, By Pathogen

6.2.1 Overview and Analysis

6.2.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Streptococcus Pneumoniae (DRSP), 2021- 2031F

6.2.3 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Campylobacter (DRC), 2021- 2031F

6.2.4 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Clostridium Difficile (CD), 2021- 2031F

6.2.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Methicillin Resistant Staphylococcus Aureus (MRSA), 2021- 2031F

6.2.6 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Neisseria Gonorrhoeae (DRNG), 2021- 2031F

6.2.7 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Salmonella (DRNTS), 2021- 2031F

6.3 United States (US) Antimicrobial Resistance Diagnostics Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.3.4 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F

6.3.5 United States (US) Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Antimicrobial Resistance Diagnostics Market Import-Export Trade Statistics

7.1 United States (US) Antimicrobial Resistance Diagnostics Market Export to Major Countries

7.2 United States (US) Antimicrobial Resistance Diagnostics Market Imports from Major Countries

8 United States (US) Antimicrobial Resistance Diagnostics Market Key Performance Indicators

8.1 Percentage increase in the adoption rate of antimicrobial resistance diagnostics in US healthcare facilities

8.2 Number of research and development partnerships between diagnostic companies and healthcare institutions focused on antimicrobial resistance

8.3 Average turnaround time for antimicrobial resistance diagnostic test results in the US

8.4 Percentage of healthcare professionals trained in the proper use and interpretation of antimicrobial resistance diagnostic tests

9 United States (US) Antimicrobial Resistance Diagnostics Market - Opportunity Assessment

9.1 United States (US) Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F

9.3 United States (US) Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United States (US) Antimicrobial Resistance Diagnostics Market - Competitive Landscape

10.1 United States (US) Antimicrobial Resistance Diagnostics Market Revenue Share, By Companies, 2024

10.2 United States (US) Antimicrobial Resistance Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Antimicrobial Resistance Diagnostics Market

Brunei Antimicrobial Resistance Diagnostics Market

Bulgaria Antimicrobial Resistance Diagnostics Market

Burkina Faso Antimicrobial Resistance Diagnostics Market

Burundi Antimicrobial Resistance Diagnostics Market

Cameroon Antimicrobial Resistance Diagnostics Market

Global Antimicrobial Resistance Diagnostics Market

Middle East Antimicrobial Resistance Diagnostics Market

North America Antimicrobial Resistance Diagnostics Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here